Literature DB >> 17447732

Comparative kinetics of cofactor association and dissociation for the human and trypanosomal S-adenosylhomocysteine hydrolases. 1. Basic features of the association and dissociation processes.

Qing-Shan Li1, Sumin Cai, Ronald T Borchardt, Jianwen Fang, Krzysztof Kuczera, C Russell Middaugh, Richard L Schowen.   

Abstract

The S-adenosyl-l-homocysteine (AdoHcy) hydrolases catalyze the reversible conversion of AdoHcy to adenosine and homocysteine, making use of a catalytic cycle in which a tightly bound NAD+ oxidizes the 3-hydroxyl group of the substrate at the beginning of the cycle, activating the 4-CH bond for elimination of homocysteine, followed by Michael addition of water to the resulting intermediate and a final reduction by the tightly bound NADH to give adenosine. The equilibrium and kinetic properties of the association and dissociation of the cofactor NAD+ from the enzymes of Homo sapiens (Hs-SAHH) and Trypanosoma cruzi (Tc-SAHH) are qualitatively similar but quantitatively distinct. Both enzymes bind NAD+ in a complex scheme. The four active sites of the homotetrameric apoenzyme appear to divide into two numerically equal classes of active sites. One class of sites binds cofactor weakly and generates full activity very rapidly (in less than 1 min). The other class binds cofactor more strongly but generates activity only slowly (>30 min). In the case of Tc-SAHH, the final affinity for NAD+ is roughly micromolar and this affinity persists as the equilibrium affinity. In the case of Hs-SAHH, the slow-binding phase terminates in micromolar affinity also, but over a period of hours, the dissociation rate constant decreases until the final equilibrium affinity is in the nanomolar range. The slow binding of NAD+ by both enzymes exhibits saturation kinetics with respect to the cofactor concentration; however, binding to Hs-SAHH has a maximum rate constant around 0.06 s-1, while the rate constant for binding to Tc-SAHH levels out at 0.006 s-1. In contrast to the complex kinetics of association, both enzymes undergo dissociation of NAD+ from all four sites in a single first-order reaction. The equilibrium affinities of both Hs-SAHH and Tc-SAHH for NADH are in the nanomolar range. The dissociation rate constants and the slow-binding association rate constants for NAD+ show a complex temperature dependence with both enzymes; however, the cofactor always dissociates more rapidly from Tc-SAHH than from Hs-SAHH, the ratio being around 80-fold at 37 degrees C, and the cofactor binds more rapidly to Hs-SAHH than to Tc-SAHH above approximately 16 degrees C. These features present an opening for selective inhibition of Tc-SAHH over Hs-SAHH, demonstrated with the thioamide analogues of NAD+ and NADH. Both analogues bind to Hs-SAHH with approximately 40 nM affinities but much more weakly to Tc-SAHH (0.6-15 microM). Nevertheless, both analogues inactivated Tc-SAHH 60% (NAD+ analogue) or 100% (NADH analogue) within 30 min, while the degree of inhibition of Hs-SAHH approached 30% only after 12 h. The rate of loss of activity is equal to the rate of dissociation of the cofactor and thus 80-fold faster at 37 degrees C for Tc-SAHH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17447732     DOI: 10.1021/bi700170m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Evaluation of NAD(H) analogues as selective inhibitors for Trypanosoma cruzi S-adenosylhomocysteine hydrolase.

Authors:  Qing-Shan Li; Sumin Cai; Jianwen Fang; Ronald T Borchardt; Krzysztof Kuczera; C Russell Middaugh; Richard L Schowen
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2009-05       Impact factor: 1.381

2.  The rationale for targeting the NAD/NADH cofactor binding site of parasitic S-adenosyl-L-homocysteine hydrolase for the design of anti-parasitic drugs.

Authors:  Sumin Cai; Qing-Shan Li; Jianwen Fang; Ronald T Borchardt; Krzysztof Kuczera; C Russell Middaugh; Richard L Schowen
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2009-05       Impact factor: 1.381

3.  Comparative kinetics of cofactor association and dissociation for the human and trypanosomal S-adenosylhomocysteine hydrolases. 3. Role of lysyl and tyrosyl residues of the C-terminal extension.

Authors:  Sumin Cai; Jianwen Fang; Qing-Shan Li; Ronald T Borchardt; Krzysztof Kuczera; C Russell Middaugh; Richard L Schowen
Journal:  Biochemistry       Date:  2010-09-28       Impact factor: 3.162

4.  Luciferase-based assay for adenosine: application to S-adenosyl-L-homocysteine hydrolase.

Authors:  Emmanuel S Burgos; Shivali A Gulab; María B Cassera; Vern L Schramm
Journal:  Anal Chem       Date:  2012-03-28       Impact factor: 6.986

Review 5.  Metabolic Signaling to Chromatin.

Authors:  Shelley L Berger; Paolo Sassone-Corsi
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-11-01       Impact factor: 10.005

6.  TNFalpha-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafish S-adenosylhomocysteine hydrolase.

Authors:  Randolph P Matthews; Kristin Lorent; Rafael Mañoral-Mobias; Yuehua Huang; Weilong Gong; Ian V J Murray; Ian A Blair; Michael Pack
Journal:  Development       Date:  2009-03       Impact factor: 6.868

7.  Determinants for the cAMP-binding site at the S-adenosylhomocysteine-hydrolase.

Authors:  Doris Kloor; Marina Hermes; Julia Kirschler; Margret Müller; Norbert Hagen; Hubert Kalbacher; Stefan Stevanovic; Hartmut Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-06-23       Impact factor: 3.000

8.  The antiviral drug ribavirin is a selective inhibitor of S-adenosyl-L-homocysteine hydrolase from Trypanosoma cruzi.

Authors:  Sumin Cai; Qing-Shan Li; Ronald T Borchardt; Krzysztof Kuczera; Richard L Schowen
Journal:  Bioorg Med Chem       Date:  2007-08-24       Impact factor: 3.641

9.  S-Adenosyl-L-Homocysteine Hydrolase Inhibition by a Synthetic Nicotinamide Cofactor Biomimetic.

Authors:  Lyn L Kailing; Daniela Bertinetti; Caroline E Paul; Tomasz Manszewski; Mariusz Jaskolski; Friedrich W Herberg; Ioannis V Pavlidis
Journal:  Front Microbiol       Date:  2018-03-21       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.